$3,500,000 EBITDA TRAINING COMPANY FOR PHARMACEUTICAL REPS IN CONNECTICUT

Seeking capital for acquisition.
Highly profitable training company for pharmaceutical reps. Consistent 50%+ margins for years. Company established[redacted]Owner illness. Covid dip has made EV a great value. Poised to quickly return to pre-covid revenue levels of $8MM+. LOI signed. Equity raise. Teaser attached.

industry
[redacted]
location
[redacted]
revenue
[redacted]
ebitda
[redacted]
proposed price
[redacted]
owner financing
[redacted]
target debt
[redacted]
target equity
[redacted]

It appears you don't have a PDF plugin for this browser.

Click here to download the PDF file.



share: